Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI


Primary Symbol: V.BTI.H Alternate Symbol(s):  BIOAF

Healthcare Biotechnology
Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs
Bullboard Posts
User Avatar Image
(2146)
•••
Post by jdstoxon Sep 06, 2017 4:55pm
278 Views
Post# 26663418

Upcoming Roadshow and AGM

Upcoming Roadshow and AGMLet the bells ring and the banners fly, jdstox is coming to town.

I have decided to leave the smokey confines of Interior BC and take a couple of trips.

I will be in Kelowna on September 14 at the biOasis presentation at the Kelowna Golf & Country Club at 2 PM. It's a great chance to visit family and after all these years to finally hear a biOasis presentation.  

And I'm also going to the AGM on Sept 21. I'll probably hang around Vancouver for a couple of days.This is going to be a great chance to meet people that I've talked with for years but have never met.

And, hey!

Have you gotten your proxies off recently?

Get your proxies out! 

So you can take some credit for your judicious choice of management and board if they turn this into the big winner we so richly deserve.

Kelowna. Vancouver. AGM. 

Be there or be square.

jd
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities